businesspress24.com - WorldCare Clinical Exhibits at 22nd Partnerships in Clinical Trials and Joins Massachusetts General
 

WorldCare Clinical Exhibits at 22nd Partnerships in Clinical Trials and Joins Massachusetts General Hospital (MGH) Department of Radiology and Harvard Medical School Department of Continuing Education at "Imaging Biomarkers in Clinical Trials"

ID: 1219401

(firmenpresse) - BOSTON, MA -- (Marketwired) -- 04/23/13 -- WorldCare Clinical, LLC (WCC), a leading imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced it is exhibiting at this week's 22nd annual Partnerships in Clinical Trials conference at Booth #921. Partnerships is an active community of more than 13,000 members with a worldwide focus on delivering higher quality standards in clinical research and development.

Additionally, WCC joins MGH and Harvard Medical School at the upcoming "Imaging Biomarkers in Clinical Trials -- Focus on Oncology," to be held in the O'Keefe Auditorium at MGH in Boston. The educational format of the conference will give attendees an opportunity to review the current practice of imaging biomarkers in clinical trials in oncology with radiology experts from MGH, as well as discuss advanced imaging techniques that have potential as surrogate biomarkers. Case studies of previous clinical trials and their successes and failures will also be referenced. "Imaging Biomarkers in Clinical Trials" will take place April 26-27, 2013. For more information or to register or to register, visit

WorldCare Clinical (WCC) is a leading imaging CRO that employs imaging expertise, innovative technology and operational excellence to maximize the precision and accuracy of a blinded independent central review of clinical trial data. Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WCC has evolved as an independent company while maintaining a strategic relationship with MGH. With a 20-year focus on imaging trials and their specific requirements, WCC provides sponsors with extensive medical, operational, and image management expertise in support of even the most complex study designs. For more information, visit .





For more information, contact:
Bree Bolognese
SVM Public Relations
(760) 754-7025






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for Its Hair Regeneration Technology
Corcept Therapeutics to Announce First Quarter 2013 Financial Results and Host Conference Call
Bereitgestellt von Benutzer: Marketwired
Datum: 23.04.2013 - 11:15 Uhr
Sprache: Deutsch
News-ID 1219401
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

BOSTON, MA


Phone:

Kategorie:

Trials


Anmerkungen:


Diese Pressemitteilung wurde bisher 367 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"WorldCare Clinical Exhibits at 22nd Partnerships in Clinical Trials and Joins Massachusetts General Hospital (MGH) Department of Radiology and Harvard Medical School Department of Continuing Education at "Imaging Biomarkers in Clinical Trials"
"
steht unter der journalistisch-redaktionellen Verantwortung von

WorldCare Clinical (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von WorldCare Clinical



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 112


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.